D. Immune Complex-Mediated Vasculitis
  • Philip Seo


  • Pathogenic immune complexes formed between antigen and antibodies tend to occur during periods of antigen excess. When the immune complexes precipitate into the tissues, they fix complement, leading to an intense immune reaction.

  • In immune complex vasculitis, immune complexes deposit in the vascular endothelium or in capillary beds, such as those found in the skin, kidneys, or lungs.

  • The most common skin manifestation of small vessel vasculitis is palpable purpura.

  • Hypersensitivity vasculitis is characterized by immune complex deposition in capillaries, postcapillary venules, and arterioles. The usual causes are either medications (e.g., penicillins, sulfonamides, or cephalosporins) or infections.

  • Cryoglobulinemic vasculitis is usually caused by hepatitis C infections. The antigens involved in cryoglobulinemic vasculitis are portions of the hepatitis C virus (HCV) virion. The relevant antibodies are both IgG and IgM, leading to the designation

  • “mixed” cryoglobulinemia.

  • Henoch-Schönlein purpura is associated strongly with IgA deposition within blood vessel walls.

  • ■ Hypocomplementemic urticarial vasculitis has many features that overlap with systemic lupus erythematosus.


Chronic Obstructive Pulmonary Disease Immune Complex Chronic Urticaria Leukocytoclastic Vasculitis Small Vessel Vasculitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 2005;9:183–191.PubMedCrossRefGoogle Scholar
  2. 2.
    Arthus M. Injections repetees de serum de cheval cuez le lapin. Seances et Memoire de la Societe de Biologie 1903;55:817–825.Google Scholar
  3. 3.
    Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990;33:1108–1113.PubMedCrossRefGoogle Scholar
  4. 4.
    Wintrobe MM, Buell MV. Hyperproteinemia associated with multiple myeloma: with report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud’s disease. Bulletin Johns Hopkins Hosp 1933;52:156.Google Scholar
  5. 5.
    Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006;18:54–63.PubMedCrossRefGoogle Scholar
  6. 6.
    Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990;33:1114–1121.PubMedCrossRefGoogle Scholar
  7. 7.
    Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M, Gonzalez-Gay MA. Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 1997;40:859–864.PubMedCrossRefGoogle Scholar
  8. 8.
    Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch-Schonlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001;21:128–133.PubMedCrossRefGoogle Scholar
  9. 9.
    Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 2004;24:183–213.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Philip Seo
    • 1
  1. 1.Johns Hopkins Vasculitis Center, Division of RheumatologyJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations